Skip to main content
Publication date
2018 05
Authors
Kapoor, R Ho, PR Campbell, N Chang, I Deykin, A Forrestal, F Lucas, N Yu, B Arnold, DL Freedman, M Goldman, MD Hartung, HP Kubala Havrdova, E Jeffery, D Miller, A Sellebjerg, F Cadavid, D Mikol, D Steiner, D
Group authors
Investigators, A
Pubmed ID
29545067
Journal
The Lancet. Neurology
Doctype
Article
KI Connection
Låg
Mesh SV
Dubbelblindmetod Forskningsplanering Hand Immunfaktorer Kvinnlig Manlig Medelålders personer Multipel skleros, kronisk progressiv Människa Natalizumab Resultatvärdering (Hälso- och sjukvård) Sjukdomsförlopp Sjukdomsgradsmått Unga vuxna Ungdomar Vuxna
Mesh EN
Disease Progression Double-Blind Method Hand Immunologic Factors Multiple Sclerosis, Chronic Progressive Natalizumab Outcome Assessment (Health Care) Research Design Severity of Illness Index
First date
2018-05-21T01:42:53.23Z